STAT
AUGUST 23, 2024
I’m a doctor and epidemiologist, so you might expect me to be religious about preventative care: yearly visits to my primary care physician, that sort of thing. But I know we can’t prevent most disease and a lot of what we do in medicine doesn’t add value and sometimes even causes harm. So instead, I practice a seemingly radical but necessary idea for getting the best from medicine while avoiding excesses.
PharmaVoice
AUGUST 19, 2024
With fewer side effects, the new wave of upcoming drugs could improve patient adherence, and the competition for a large projected market is getting fierce.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
AUGUST 22, 2024
200,000 people in the UK have what is considered a ‘hidden’ lung condition
Fuld & Company Blog
AUGUST 22, 2024
Generative AI (Gen AI) is revolutionizing the mergers and acquisitions (M&A) process with adoption by M&A practitioners set to increase by 90% by 2025. This growth in adoption is driven by the significant benefits Gen AI offers, including streamlining target sourcing, helping refine strategies, and improving post-merger integrations. Gen AI is driving greater efficiency and addressing complex data challenges throughout the deal-making process.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
AUGUST 21, 2024
Merck’s Ebola vaccine offered substantial protection to people vaccinated during the 2018-2020 outbreak in the Democratic Republic of the Congo, with an effectiveness of 84% in those who had been vaccinated at least 10 days before being exposed to the virus, a new study reports. An earlier study had shown that people who were vaccinated but went on to develop the disease were more likely to survive the infection.
PharmaVoice
AUGUST 20, 2024
Dr. Jennifer Low, head of 23andMe’s therapeutics division, is taking the company into new territory with a potential cancer treatment that targets a unique pathway.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
AUGUST 21, 2024
The new test takes an average of 13 hours to identify the correct treatment compared to several days with current methods
STAT
AUGUST 21, 2024
Rachel Gross wants to clear up misconceptions about children and Covid-19. A pediatrician and population health researcher, she recalls a time four years ago when people didn’t think children could even contract the disease. Then, after accepting kids’ vulnerability to the virus, it was thought only adults could suffer from the myriad symptoms that persist or crop up post-infection, collectively known as long Covid.
Fuld & Company Blog
AUGUST 20, 2024
Fuld & Company Director, Vinit Gala, interview s Gaurav Bhasin, Managing Director at Allied Advisers, on the latest trends and developments in investment banking. They discuss recent deal activity, the impact of potential US Fed rate changes, and the evolving roles of private credit and AI in investment banking. How would you assess the deal activity for H1 2024?
pharmaphorum
AUGUST 19, 2024
Walgreens has signed a $100m contract with the US government's BARDA agency for access to its decentralised clinical trials network
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Times
AUGUST 21, 2024
Globally 400,000 children are impacted every year by cancers that include leukaemia and lymphoma
STAT
AUGUST 21, 2024
Megan Hanson was eight weeks pregnant in 2019 when she experienced a miscarriage — her sixth consecutive loss in as many years. It felt particularly cruel after a second IVF transfer. She and her husband, Ben Burnham, were devastated, physically and financially drained — and deeply frustrated by the lack of answers or support for people like them who had experienced recurrent miscarriages.
The Pharmacist
AUGUST 19, 2024
Pharmacy bodies have highlighted funding, workforce and medicine supply concerns to an independent review intended to 'diagnose' the challenges facing the NHS. Health and social care secretary Wes Streeting has commissioned the Darzi review to deliver 'a raw and frank assessment of the state of the NHS' next month. 'This is the necessary first step […] The post Pharmacy crises highlighted in 'honest' NHS review appeared first on The Pharmacist.
PharmaVoice
AUGUST 22, 2024
Greg Friberg and James Sabry will take over, respectively, as heads of R&D and business development, less than a year after BioMarin named a new CEO.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharma Times
AUGUST 23, 2024
The conference will be held in Basel, Switzerland from 26-28 August
STAT
AUGUST 20, 2024
Eli Lilly’s obesity drug Zepbound significantly cut the risk of developing type 2 diabetes, showing the benefits of long-term use of the blockbuster therapy. In a Phase 3 trial that lasted over three years, people with pre-diabetes taking Zepbound had a 93% lower risk of progressing to diabetes compared with people on placebo, Lilly said Tuesday.
pharmaphorum
AUGUST 20, 2024
GSK gets FDA breakthrough status for its B7-H3 directed ADC, licensed from Hansah Pharma in a $1.
PharmaVoice
AUGUST 22, 2024
There’s no link between revenue and R&D from smaller biotechs, and that’s where most innovation comes from, according to new studies.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Times
AUGUST 23, 2024
Most cases go undetected until an advanced stage, as the disease rarely causes early symptoms
STAT
AUGUST 19, 2024
Private equity firms are sucking the resources out of America’s hospitals and nursing homes, and feeding on doctors to generate profits. These firms — which pool funds from wealthy investors and are exempt from many of the regulations and disclosure requirements that apply to other types of investments — have spent a half-trillion dollars since 2018 buying up medical resources.
Express Pharma
AUGUST 21, 2024
The popularity of glucagon-like peptide-1 receptor (GLP-1R) drugs has exploded in recent years due to their ability to effectively treat metabolic-related disorders such as obesity and type 2 diabetes. As obesity rates rise and trust in GLP-1R products grows, sales for drugs targeting this receptor are forecast to increase fourfold to an estimated $142 billion by 2030.
PharmaVoice
AUGUST 21, 2024
The Supreme Court case added another layer of uncertainty on the regulatory front and opened up the Inflation Reduction Act to more legal attacks.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharma Times
AUGUST 22, 2024
The grant will support clinical trials of rare disease therapy for leukodystrophy
STAT
AUGUST 19, 2024
Peter Orszag was instrumental in crafting the Affordable Care Act. Now, he wants federal antitrust authorities to ease up on their sharp scrutiny of health care transactions that he acknowledges the law has encouraged — and that make a lot of money for his investment bank. Orszag’s comments, made last week on TV, reveal how policymakers can end up profiting from the laws they help create.
pharmaphorum
AUGUST 21, 2024
Demonstrating EVERSANA's dedication to innovation, a novel artificial intelligence technology is set to enhance the NAVLIN experience for both current and prospective customers.
PharmaVoice
AUGUST 19, 2024
The new factory, which Novo is committing some $220 million to build, will supply raw materials for the company’s chronic disease medicines.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharma Times
AUGUST 19, 2024
The contract concerns profiling Immunoglobulin E autoantibodies in blood serum
STAT
AUGUST 22, 2024
WASHINGTON — U.S. regulators approved updated Covid-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter, too. With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses. A third U.S. manufacturer, Novavax, expects its updated vaccine version to be available a little later.
The Pharmacist
AUGUST 23, 2024
High and medium-level supply notifications have been issued for norethisterone, methylphenidate prolonged-release and some naltrexone medications. 'High impact' ADHD med shortage may require paper prescriptions Yesterday (22 August) the Department of Health and Social Care (DHSC) issued a 'high impact' medicine supply notification for methylphenidate prolonged-release tablets.
BioPharma Dive
AUGUST 19, 2024
A new wave of antipsychotics could improve patient adherence. The race to corner this large projected market is already getting tight.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
363 
Let's personalize your content